Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026)
Atea Pharmaceuticals' (AVIR) quarterly Tax Provisions came in at $50000.0 in Q1 2026, down 75.37% year-on-year from $203000.0 in Q1 2025, and up 100.74% quarter-over-quarter from -$6.8 million in Q4 2025.
Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 75.37% year-over-year to $50000.0 in Q1 2026; TTM through Mar 2026 was -$6.3 million, a 804.01% decrease from a year earlier, with the FY2025 full-year figure at -$6.2 million, down 766.16% from the prior year.
- Tax Provisions grew to $50000.0 in Q1 2026 per AVIR's latest filing, from -$6.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $349000.0 in Q4 2023 and bottomed at -$6.8 million in Q4 2025.
- The 5-year median for Tax Provisions is $205000.0 (2025), against an average of -$484937.5.
- Across the five-year window, Tax Provisions surged 183.74% in 2023 and sank 3108.0% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $123000.0 in 2022, then jumped by 183.74% to $349000.0 in 2023, then sank by 35.53% to $225000.0 in 2024, then sank by 3108.0% to -$6.8 million in 2025, then surged by 100.74% to $50000.0 in 2026.
- Per Business Quant, the three latest AVIR Tax Provisions figures stand at $50000.0 (Q1 2026), -$6.8 million (Q4 2025), and $196000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Atea Pharmaceuticals | 374.61 Mn | 374.61 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | -6.77 Mn |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 243,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | -3.83 Mn |
| Jun 30, 2022 | 120,000.00 |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 6.10 Mn |
| Jun 30, 2021 | 7.20 Mn |